HOOK:HOOKIPA Pharma Inc - Stock Price Quote and Dividend Data
HOOK STOCK PRICE LATEST CLOSE
$0.75
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
HOOKIPA Pharma Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
HOOKIPA Pharma Inc Stock Price Information
52-Week Low/High Stock Price$0.75 - $10.50
Percent Held by Institutions8.04%
Revenue$45,300,000
Net Income$-68,453,000
Cash Flow$-97,916,000
EPS-1.99%
Market Cap$7,264,320
PE Ratio0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-91.15%
Total Return Last 3 Years-95.89%
Total Return Last 5 Years-99.04%
Latest Trade DateApr. 08, 2025
HOOKIPA Pharma Inc Annual Stock Dividends
No Data available for Payment History.
HOOKIPA Pharma Inc Dividend Payment History
| No dividends retrieved for HOOK |
HOOKIPA Pharma Inc Other Dividend Details
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Co.'s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 03, 2025HOOK STOCK PRICE DECREASE: HOOKIPA Pharma Inc on 04-03-2025 decreased stock price > 10% from $1.03 to $0.92
Mar. 13, 2025HOOK STOCK PRICE INCREASE: HOOKIPA Pharma Inc on 03-13-2025 increased stock price > 10% from $1.11 to $1.25
Mar. 12, 2025HOOK STOCK PRICE 52 WEEK LOW: HOOKIPA Pharma Inc on 03-12-2025 hit a 52 week low of $1.11
Mar. 11, 2025HOOK STOCK PRICE 52 WEEK LOW: HOOKIPA Pharma Inc on 03-11-2025 hit a 52 week low of $1.20
Mar. 06, 2025HOOK STOCK PRICE 52 WEEK LOW: HOOKIPA Pharma Inc on 03-06-2025 hit a 52 week low of $1.34
Mar. 04, 2025HOOK STOCK PRICE 52 WEEK LOW: HOOKIPA Pharma Inc on 03-04-2025 hit a 52 week low of $1.41
Feb. 13, 2025HOOK STOCK PRICE INCREASE: HOOKIPA Pharma Inc on 02-13-2025 increased stock price > 10% from $1.69 to $1.89
Feb. 12, 2025HOOK STOCK PRICE 52 WEEK LOW: HOOKIPA Pharma Inc on 02-12-2025 hit a 52 week low of $1.69
Jan. 14, 2025HOOK STOCK PRICE DECREASE: HOOKIPA Pharma Inc on 01-14-2025 decreased stock price > 10% from $2.15 to $1.78
Jan. 11, 2025HOOK STOCK PRICE INCREASE: HOOKIPA Pharma Inc on 01-11-2025 increased stock price > 10% from $1.86 to $2.15
Apr. 09, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-09-2025 decreased stock price > 10% from $16.45 to $14.21
Apr. 09, 2025RNTX STOCK PRICE DECREASE: Rein Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $1.64 to $1.39
Apr. 09, 2025IRD STOCK PRICE DECREASE: Opus Genetics Inc on 04-09-2025 decreased stock price > 10% from $0.85 to $0.75
Apr. 09, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $4.05 to $3.61
Apr. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 04-09-2025 decreased stock price > 10% from $1.26 to $1.13
Apr. 09, 2025KAPA STOCK PRICE DECREASE: Kairos Pharma Ltd on 04-09-2025 decreased stock price > 10% from $1.14 to $0.97
Apr. 09, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-09-2025 decreased stock price > 10% from $0.87 to $0.65
Apr. 09, 2025ZBIO STOCK PRICE DECREASE: Zenas BioPharma Inc on 04-09-2025 decreased stock price > 10% from $7.75 to $6.77
Apr. 09, 2025EVOK STOCK PRICE DECREASE: Com Par $0.0001/Evoke Pharma Inc on 04-09-2025 decreased stock price > 10% from $2.35 to $2.07
Apr. 09, 2025TNFA STOCK PRICE DECREASE: TNF Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $0.37 to $0.26
